睡眠模式和药物治疗在儿童注意力缺陷障碍与多动性之间的关联:一个系统性审查
Nathalia Sena Rocha1, Rogério do Espírito Santo Amorim Correa1, Adria Carolina de Melo Dias1
1Universidade do Estado do Pará, Marabá, PA, Brasil.
对注意力缺陷多动症 (ADHD) 的药理疗法可以改善症状,但可能会对儿童的睡眠产生负面影响. 与其他ADHD药物相比,阿托莫克赛丁似乎具有较少的与睡眠有关的副作用.
科学领域:
- 儿科神经学 儿科神经学
- 睡眠医学 睡眠医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 注意缺陷多动症 (ADHD) 是儿童常见的一种神经发育障碍.
- 在患有多动症的儿童中,经常观察到睡眠障碍,影响他们的日常功能和治疗结果.
结论:
- 对ADHD的药理干预可以对儿科患者的睡眠质量产生负面影响.
- 在被研究的ADHD药物中,阿托莫克赛丁对睡眠变量的影响相对较低.
更多相关视频
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
相关概念视频
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Management of Insomnia
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Drug Therapy
Antianxiety Medications
